Recruiting
Phase 3

REACT

Sponsor:

Prokidney

Code:

NCT05099770

Conditions

Type 2 Diabetes Mellitus

Chronic Kidney Diseases

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Renal Autologous Cell Therapy (REACT/ rilparencel)

Sham Comparator

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-26. This information was provided to ClinicalTrials.gov by Prokidney on 2026-03-23.